Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Annabel Garcia-Leon"'
Autor:
Sofía Fernández-de-Retana, Mary Cano-Sarabia, Paula Marazuela, Jose Luis Sánchez-Quesada, Annabel Garcia-Leon, Alex Montañola, Joan Montaner, Daniel Maspoch, Mar Hernández-Guillamon
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Abstract Cerebral β-amyloidosis is a major feature of Alzheimer’s disease (AD), characterized by the accumulation of β-amyloid protein (Aβ) in the brain. Several studies have implicated lipid/lipoprotein metabolism in the regulation of β-amyloi
Externí odkaz:
https://doaj.org/article/8ea237bfff65468695d651045054d123
Autor:
Naroa Serna, Victor Pallarès, Ugutz Unzueta, Annabel Garcia-Leon, Eric Voltà-Durán, Alejandro Sánchez-Chardi, Eloi Parladé, Ariana Rueda, Isolda Casanova, Aïda Falgàs, Lorena Alba-Castellón, Jorge Sierra, Antonio Villaverde, Esther Vázquez, Ramón Mangues
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
JOURNAL OF CONTROLLED RELEASE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Universitat Autònoma de Barcelona
JOURNAL OF CONTROLLED RELEASE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Altres ajuts: Marató de TV3 Foundation (grant 201941-30-31-32) Self-assembling non-immunoglobulin scaffold proteins are a promising class of nanoscale carriers for drug delivery and interesting alternatives to antibody-based carriers that are not su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9363d9ef783b33ca4d31ebcc4aa95829
https://ddd.uab.cat/record/251876
https://ddd.uab.cat/record/251876
Autor:
Petri T. Kovanen, José Luis Sánchez-Quesada, Lídia Cedó, Núria Plana, Anna-Kaisa Ruotsalainen, Josep Julve, Anna-Liisa Levonen, M. Lee-Rueckert, Mireia Tondo, Lluís Masana, Noemi Rotllan, Karen Alejandra Méndez-Lara, Annabel Garcia-Leon, Matti Jauhiainen, Jari Metso, D. Santos, Mercedes Heras, Francisco Blanco-Vaca, Victor Pallarès, Andrea Rivas-Urbina, Sonia Sabate-Soler, Joan Caries Escola-Gil
Publikováno v:
Atherosclerosis. 315:e24-e25
Autor:
Mary Cano-Sarabia, Daniel Maspoch, José Luis Sánchez-Quesada, Paula Marazuela, Joan Montaner, Mar Hernández-Guillamon, Alex Montañola, Sofia Fernández-de-Retana, Annabel Garcia-Leon
Publikováno v:
Scientific Reports
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Altres ajuts: Fundació La Marató de TV3 [40/U/2014] Cerebral β-amyloidosis is a major feature of Alzheimer's disease (AD), characterized by the accumulation of β-amyloid protein (Aβ) in the brain. Several studies have implicated lipid/lipoprotei
Autor:
Aïda Falgàs, Annabel Garcia-León, Yáiza Núñez, Naroa Serna, Laura Sánchez-Garcia, Ugutz Unzueta, Eric Voltà-Durán, Marc Aragó, Patricia Álamo, Lorena Alba-Castellón, Jorge Sierra, Alberto Gallardo, Antonio Villaverde, Esther Vázquez, Ramon Mangues, Isolda Casanova
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 150, Iss , Pp 112940- (2022)
High rates of relapsed and refractory diffuse large B-cell lymphoma (DLBCL) patients and life-threatening side effects associated with immunochemotherapy make an urgent need to develop new therapies for DLBCL patients. Immunotoxins seem very potent a
Externí odkaz:
https://doaj.org/article/48b64a5a2e364d00bfca4db18c016d49
Autor:
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vázquez, Antonio Villaverde, Ramon Mangues, Isolda Casanova
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 727 (2023)
Despite advances in the development of targeted therapies for acute myeloid leukemia (AML), most patients relapse. For that reason, it is still necessary to develop novel therapies that improve treatment effectiveness and overcome drug resistance. We
Externí odkaz:
https://doaj.org/article/64a89ba3101d4368935e446254b12093
Autor:
Naroa Serna, Aïda Falgàs, Annabel García-León, Ugutz Unzueta, Yáiza Núñez, Alejandro Sánchez-Chardi, Carlos Martínez-Torró, Ramón Mangues, Esther Vazquez, Isolda Casanova, Antonio Villaverde
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 192 (2022)
The sustained release of small, tumor-targeted cytotoxic drugs is an unmet need in cancer therapies, which usually rely on punctual administration regimens of non-targeted drugs. Here, we have developed a novel concept of protein–drug nanoconjugate
Externí odkaz:
https://doaj.org/article/388ee8da4cd04eafb47d18c0533955fc